Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers

Mostrar otras versiones (1)

Tobacco smoking remains the leading cause of preventable death worldwide and current smoking cessation medications have limited efficacy. Thus, there is a clear need for translational research focused on identifying novel pharmacotherapies for nicotine addiction. Our previous studies demonstrated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashare, R L, Kimmey, B A, Rupprecht, L E, Bowers, M E, Hayes, M R, Schmidt, H D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068882/
https://www.ncbi.nlm.nih.gov/pubmed/26784967
http://dx.doi.org/10.1038/tp.2015.209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068882/
https://www.ncbi.nlm.nih.gov/pubmed/26784967
http://dx.doi.org/10.1038/tp.2015.209

Ejemplares similares